Fig. 1
From: Prevalence and risk of hepatitis E virus infection in the HIV population of Nepal
Age-specific prevalence of anti-HEV IgM and anti-HEV IgG in control subjects and HIV-infected subjects. Anti HEV IgM: blood donors versus HIV-positive individuals: age < 20 (p = 0.04); age 21–30 (p = 0.021); age 31–40 (p = 0.00); age 41–50 (p = 0.21); age 51–60 (p = 1.0). Anti HEV IgG: blood donors versus HIV-positive individuals: age < 20 (p = 0.021); age 21–30 (p = 0.00); age 31–40 (p = 0.00); age 41–50 (p = 0.00); age 51–60 (p = 0.00)